Please enable javascript in your browser to view this site

Arcep

New regulation for wholesale broadband access markets in France

ARCEP finalised the new analysis for Markets 3a, 3b, and 4, for the period 2021–2023.

ARCEP extends network sharing agreement between Orange and Free Mobile

The French regulator approved a two-year extension, which will allow Free Mobile to roam on Orange’s network until 2022.

French regulator sets out its future approach to wholesale fibre pricing

ARCEP will differentiate between new ‘fibre zones’ with different types of price controls in the high-quality access market.

ARCEP completes second phase of 3.4–3.8GHz spectrum award

The auction raised €2.79bn for 15-year licences – a price in line with other European countries for the same spectrum.

ARCEP updates its Code of Conduct on internet quality of service

The French regulator introduces new requirements for testing services such as an increase in testing capacity and the provision of additional information to users.

Arcep unveils draft review of the French fixed access market

The regulator looks to speed up copper switch-off, and to impose symmetrical QoS requirements for fibre.

Orange and Free Mobile seek extension to roaming agreement in France

The French regulator ARCEP will have to approve the two-year extension, which would allow Free to roam on Orange’s network until 2022.

French Government targets full-fibre for all by 2025

The Government announced a new target as part of its “Très Haut Debit” plan, to achieve 100% coverage of full fibre by 2025, compared to the current 45.7%.

Arcep publishes its decision on the upcoming 5G auction in France

Arcep publishes its decision on the upcoming 5G auction in France

The regulator has set out conditions of use of the 3.4–3.8GHz band, including the rollout obligations to be met between 2020 and 2025.

Arcep unveils first 5G tests in the 26GHz band in France

Arcep unveils first 5G tests in the 26GHz band in France

The French regulator has shared details of 11 projects it has selected for trials.